top of page
Gardening Together

Revolutionizing Therapies for Neurological Diseases  

 Healthy Ageing and Growing-up Healthy

SMDG is developing safe, innovative,  disease-modifying and life-saving  therapies for some of the most debilitating diseases our society face today. SMDG's team has focused on neurodegenerative diseases and pediatric neurological disorders as the first diseases to tackle.  We do this by utilizing our ground breaking and transformative platforms for targeted and safe delivery of therapies and genetic medicines and broad understanding of these diseases for designing first in-class therapeutics.  

Developing 21st Century Medicines 

Developing 21st century life-saving therapies requires bold vision and groundbreaking science.  We utilize our proprietary and innovative therapeutic platforms to develop precision and targeted life-saving therapies.  

Learn more about our science.

Doctor Analyzing X-Rays
Child on Wheelchair
Wild Nature

Inspired by Nature
   Engineered to Heal

We are Developing 
          Tomorrow's Medicines

Engineering Precision Targeting and Receptor Mediated

We were inspired by nature to engineer and develop therapies for most debilitating diseases with no known or limited therapies.

We are a team of internationally renowned scientists who have been recognised globally for our work in drug delivery and research. We are innovators and entrepreneurs with extensive experience in studying nature of different diseases and designing innovative therapeutics utilising the latest technologies.

 

We have embarked on an ambitious path of designing better disease-modifying and First-in-Class therapies that have the potential to be safe for patients and good for the environment. 

News & Events

Conference Mingling

Meet us at one of the upcoming conferences

Meet us at one of the upcoming conferences this year

Professor Moein Moghimi

SMDG scientists among the top scientists in the world

SMDG scientists, Professor Moein Moghimi and Dr. Christy Hunter have been named to the List of World’s Most Cited researchers

Mark Treherne headshot.jpg

Dr. Mark  Treherne joins Science Advisory Board 

Dr. Mark Treherne, a leading life science industry executive joins SMDG's Science Advisory Board.

Moein Moghimi posing in the lab_2.jpg

Pioneering Research

Our chief scientist and inventor of our Peptide Therapeutic Platforms: 

Professor Moein Moghimi's laboratory has been at the forefront of pioneering and innovative research in nanomedicine, drug delivery, and biomedical engineering for decades. His team's groundbreaking work has led to the development of advanced nanoscale technologies for targeted drug delivery, immune modulation, and diagnostic applications. By exploring novel approaches to nanocarrier design, biocompatibility, and cellular interactions, Professor Moghimi’s research has significantly influenced the fields of nanopharmacology and precision medicine. His lab's discoveries continue to pave the way for safer and more effective therapeutic strategies, ultimately transforming patient care and advancing modern medicine.

SMDG is an award-winning biotechnology company, recognised for its groundbreaking therapeutic platforms. Join us on our mission to transform the lives of patients suffering from neurological diseases and other debilitating diseases. Together, we can make a difference.
Fuids and Barriers of the CNS_edited_edited.jpg

SMDG's research paper and platform recognised

Life Sciences Innovator_edited.jpg

SMDG selected and honoured as a UK Life Sciences Innovator 2023

Innovation Showcase Facebook and LinkedIn SM Discovery Group_edited_edited.jpg

SMDG recognised as one of the most NE innovative companies 2023

sme-square-logo-230-1.png

Dr Farhangrazi recognised as a 2024 CEO of the year leading a life sciences company by the SME News 

SMDG color logo with name square_2.png

Healthy Tomorrow: Join Us on the Journey

Sign up to Receive News and Information

Follow us on Social Media

  • LinkedIn
Science Experiments

Copyright © 2025  S. M. Discovery Group. All Rights Reserved.

bottom of page